Hostname: page-component-745bb68f8f-d8cs5 Total loading time: 0 Render date: 2025-01-11T10:35:20.143Z Has data issue: false hasContentIssue false
  • English
  • Français

Question & Answer Forum

Published online by Cambridge University Press:  07 November 2014

Get access Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Other
Information
CNS Spectrums , Volume 9 , Issue S1 , 2004 , pp. 18 - 23
Copyright
Copyright © Cambridge University Press 2004

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1.DelBello, MP, Schwiers, ML, Rosenberg, HL, Strakowski, SM. A double-blind, randomized, placebo-controlled study of quetiapine as adjunctive treatment for adolescent mania. J Am Acad Child Adolesc Psychiatry. 2002;41:1216–1223.CrossRefGoogle ScholarPubMed
2.Keck, PE, Marcus, R, Tourkodimitris, S, et al.A placebo-controlled, double-blind study of the efficacy and safety of aripiprazole in patients with acute bipolar mania. Am J Psychiatry. In press.Google Scholar
3.Leverich, GS, McElroy, SL, Altshuler, LL, et al.The anticonvulsant zonisamide in bipolar illness: clinical response and weight loss. Bipolar Disord. 2003. In press.Google Scholar
4.Pande, AC, Crockatt, JG, Janney, CA, Werth, JL, Tsaroucha, G. Gabapentin in bipolar disorder: a placebo-controlled trial of adjunctive therapy. Gabapentin Bipolar Disorder Study Group. Bipolar Disord. 2000;2:249–255.CrossRefGoogle ScholarPubMed
5.Frye, MA, Ketter, TA, Kimbrell, TA, et al.A placebo-controlled study of lamotrigine and gabapentin monotherapy in refractory mood disorders. J Clin Psychopharmacol. 2000;20:607–614.CrossRefGoogle ScholarPubMed
6.Grunze, H, Erfurth, A, Marcuse, A, Amann, B, Normann, C, Walden, J. Tiagabine appears not to be efficacious in the treatment of acute mania.J Clin Psychiatry. 1999;60:759–762.CrossRefGoogle Scholar
7.Calabrese, JR, Bowden, CL, Sachs, G, et al.A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently depressed patients with bipolar I disorder. J Clin Psychiatry. 2003;9:1013–1024.CrossRefGoogle Scholar
8.Bowden, CL, Calabrese, JR, Sachs, G, et al.A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently manic or hypomanic patients with bipolar I disorder. Arch Gen Psychiatry. 2003;4:392–400.CrossRefGoogle Scholar
9.Kalali, AH, Ketter, TA, Weisler, RH. A 3-week double-blind placebo-controlled study of extended release carbamazepine in the treatment of acute mania in bipolar disorder. Presented at: 43rd Annual Meeting of the New Clinical Drug Evaluation Unit; May 27-30, 2003; Boca Raton, FL.Google Scholar
10.Kowatch, RA, Suppes, T, Carmody, TJ, et al.Effect size of lithium, divalproex sodium, and carbamazepine in children and adolescents with bipolar disorder. J Am Acad Child Adolesc Psychiatry. 2000;39:713–720.CrossRefGoogle ScholarPubMed
11.Goodwin, FK, Fireman, B, Simon, GE, Hunkeler, EM, Lee, J, Revicki, D. Suicide risk in bipolar disorder during treatment with lithium and divalproex. JAMA. 2003;11:1467–1473.CrossRefGoogle Scholar
12.Passmore, MJ, Garnham, J, Duffy, A, et al.Phenotypic spectra of bipolar disorder in responders to lithium versus lamotrigine. Bipolar Disord. 2003;5:110–114.CrossRefGoogle ScholarPubMed
13.Greil, W, Kleindienst, N, Erazo, N, Muller-Oerlinghausen, B. Differential response to lithium and carbamazepine in the prophylaxis of bipolar disorder. J Clin Psychopharmacol. 1998;18:455–460.CrossRefGoogle ScholarPubMed